Stay updated with breaking news from Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present...
-- The Company will host an investor event following the presentation after the close of market on Thursday, November 2nd -- ...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price fell 6.6% during trading on Monday . The company traded as low as $11.38 and last traded at $11.38. 132,540 shares changed hands during trading, a decline of 22% from the average session volume of 169,821 shares. The stock had previously closed at $12.19. […]
ALPN | Complete Alpine Immune Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
SEATTLE--(BUSINESS WIRE)--Oct 4, 2023--